Louisiana Department of Health, New Orleans, Louisiana (Mr Burgess and Dr Gruber); and Center for Surveillance, Epidemiology, and Laboratory Services (Dr Beltrami) and Division of HIV/AIDS Prevention (Ms Kearns), Centers for Disease Control and Prevention, Atlanta, Georgia.
J Public Health Manag Pract. 2020 Nov/Dec;26(6):590-594. doi: 10.1097/PHH.0000000000000959.
During the conduct of the described demonstration project (2012-2015), the Centers for Disease Control and Prevention funding standard for HIV testing was 1.0% newly diagnosed positivity in non-health care settings. For linkage to HIV medical care, the National HIV/AIDS Strategy goal was 85%, and the funding standard was 80% (the Centers for Disease Control and Prevention and National HIV/AIDS Strategy had no other quantified goals/standards relevant to the project).
To determine aggregate quantitative results of HIV/STD testing and engagement in HIV care.
Information sources used for this case study analysis included the Louisiana Department of Health funding application, progress and final reports submitted to the Centers for Disease Control and Prevention, and records of communications between these agencies.
Six community-based Wellness Centers throughout Louisiana.
Gay and bisexual men and transgender persons.
New HIV/STD diagnoses from testing, linkage to HIV care, and reengagement in HIV medical care.
The percentage of persons who were newly diagnosed with HIV was 1.4% (44/3214). Of the newly diagnosed persons, 91% (40/44) were linked to HIV medical care. Of persons who were identified as out of care, 83% (5/6) were reengaged in HIV medical care. STD testing results showed that 9.0% (294/3251) of the syphilis tests were positive, and 8.3% (803/9719) of the chlamydia/gonorrhea tests were positive. The pharyngeal chlamydia/gonorrhea positivity was 7.6% (256/3375); the rectal chlamydia/gonorrhea positivity was 13% (374/2948); and the urine chlamydia/gonorrhea positivity was 5.1% (173/3396).
The demonstration project was successful. The results were used to discontinue funding for a less effective HIV screening program, continue demonstration project activities with other funds, and make policy changes so that extragenital screening for chlamydia/gonorrhea is now the standard at Louisiana clinics that serve gay and bisexual men and transgender persons.
在描述的示范项目(2012-2015 年)实施期间,疾病预防控制中心对非医疗环境中艾滋病毒检测的资金标准为新诊断阳性率的 1.0%。为了将艾滋病毒感染者与医疗服务联系起来,国家艾滋病毒/艾滋病战略的目标是 85%,资金标准是 80%(疾病预防控制中心和国家艾滋病毒/艾滋病战略没有其他与项目相关的量化目标/标准)。
确定艾滋病毒/性传播疾病检测和参与艾滋病毒护理的综合定量结果。
本案例研究分析使用的信息来源包括路易斯安那州卫生部的供资申请、向疾病预防控制中心提交的进展和最终报告,以及这些机构之间的通信记录。
路易斯安那州的六个社区健康中心。
男同性恋和双性恋者以及跨性别者。
检测新诊断的艾滋病毒/性传播疾病、与艾滋病毒护理的联系以及重新参与艾滋病毒医疗护理。
新诊断为艾滋病毒的人数占 1.4%(44/3214)。在新诊断的人群中,91%(40/44)与艾滋病毒医疗护理联系起来。在确定为脱离护理的人群中,83%(5/6)重新参与艾滋病毒医疗护理。性传播疾病检测结果显示,梅毒检测阳性率为 9.0%(294/3251),衣原体/淋病检测阳性率为 8.3%(803/9719)。咽淋病/淋病阳性率为 7.6%(256/3375);直肠淋病/淋病阳性率为 13%(374/2948);尿液淋病/淋病阳性率为 5.1%(173/3396)。
示范项目取得成功。这些结果被用来停止对艾滋病毒筛查方案的资金支持,用其他资金继续示范项目活动,并进行政策改革,以便在为男同性恋和双性恋者以及跨性别者提供服务的路易斯安那州诊所中,现在将生殖道外筛查衣原体/淋病作为标准。